1 Ross R. Atherosclerosis: an inflammatory disease[J].

N Engl J Med, 1999, 340:115-126.

2 Libby P, Ridker PM, Maseri A. Inflammation and

atherosclerosis[J]. Circulation, 2002, 105:1135-1143.

3 Libby P. Inflammation in atherosclerosis[J]. Nature,

2002, 420:868-874.

4 Ikeno F, Inagaki K, Rezaee M, et al. Impaired

perfusion after myocardial infarction is due to

reperfusion-induced {delta}PKC-mediated myocardial damage[J]. Cardiovasc Res, 2007, 73:699-709.

5 Satoh K, Matoba T, Suzuki J, et al. Cyclophilin

a mediates vascular remodeling by promoting

inf lammation and vascular smooth muscle cell

proliferation[J]. Circulation, 2008, 117:3088-3098.

6 Eidelman RS, Hennekens CH. Fibrinogen: a predictor

of stroke and marker of atherosclerosis[J]. Eur Heart J,

2003, 24:499-500.

7 Paramo JA, Rodriguez JA, J Orbe. Fibrinogen. An old

hemostatic protein with a new function:non-invasive

marker of subclinical atherosclerosis[J]. Med Clin

(Barc), 2005, 124:790-794.

8 Rajtari R, Kloch M, Kiec-Wilk B, et al. Fibrinogen-

-acute phase protein as a marker of immunological

process as atherosclerosis[J]. Folia Med Cracov, 2005,

46:21-32.

9 Dosa E, Rugonfalvi-Kiss S, Prohaszka Z, et al.

Marked decrease in the levels of two inflammatory

markers, hs-C-reactive protein and fibrinogen in

patients with severe carotid atherosclerosis after

eversion carotid endarterectomy[J]. Inf lamm Res,

2004, 53:631-635.

10 Herrick S, Blanc-Brude O, Gray A, et al. Fibrinogen[J].

Int J Biochem Cell Biol, 1999, 31:741-746.

11 Keavney B, Danesh J, Parish S, et al. Fibrinogen and

coronary heart disease: test of causality by 'Mendelian

randomization'[J]. Int J Epidemiol, 2006, 35:935-943.

12 Ma YQ, Plow EF, Geng JG. P-selectin binding

to P-selectin glycoprotein ligand-1 induces an

intermediate state of {alpha}M{beta}2 activation

and acts cooperatively with extracellular stimuli to

support maximal adhesion of human neutrophils[J].

Blood, 2004, 104:2549-2556.

13 Naito M. Effects of fibrinogen, fibrin and their

degradation products on the behaviour of vascular

smooth muscle cells[J]. Nippon Ronen Igakkai Zasshi,

2000, 37:458-463.

14 Guo YH, Hernandez I, Isermann B, et al. Caveolin-

1-dependent apoptosis induced by fibrin degradation

products[J]. Blood, 2009, 113:4431-4439.

15 Yakovlev S, Zhang L, Ugarova T, et al. Interaction

of fibrin(ogen) with leukocyte receptor alpha M

domain beta 2(Mac-1): further characterization and

identication of a novel binding region within the

central domain of the fibrinogen gamma-module[J].

Biochemistry, 2005, 44:617-626.

16 曹勇军, 钱进军, 刘春风. 纤维蛋白(原)、纤维蛋白(原)

降解产物及其基序拮抗剂与动脉粥样硬化[J]. 国际脑

血管病杂志, 2006, 14:290-293.

17 Albert MA, Glynn RJ, Buring JE, et al. Relation

between soluble intercellular adhesion molecule-1,

homocysteine, and fibrinogen levels and race/ethnicity

in women without cardiovascular disease[J]. Am J

Cardiol, 2007, 99:1246-1251.

18 Guo M, Daines D, Tang J, et al. Fibrinogen-{gamma}

C-terminal fragments induce endothelial barrier

dysfunction and microvascular leak via integrinmediated

and RhoA-dependent mechanism[J ].

Arterioscler Thromb Vasc Biol, 2009, 29:394-400.

19 Tsakadze NL, Zhao Z, D’Souza SE. Interactions of

intercellular adhesion molecular-1 with fibrinogen[J].

Trends Cardiovasc Med, 2002, 12:101-108.

20 张艳林, 曹勇军, 刘春风. 血管内皮钙黏蛋白参与动

脉粥样硬化形成的机制[J]. 国际脑血管病杂志, 2009,

17:53-56.

21 Tzima E, Reader JS, Irani-Tehrani M, et al. VEcad

her in l in ks tRNA sy nthet a se cy tokine to

anti-angiogenic function[J]. J Biol Chem, 2005,

280:2405-2408.

22 Vestweber D. VE-Cadherin: the major endothelial

adhesion molecule controlling cellular junctions and

blood vessel formation[J]. Arterioscler Thromb Vasc

Biol, 2008, 28:223-232.

23 Petzelbauer P, Zacharowski PA, Miyazaki Y, et al.

The fibrin-derived peptide B Beta(15-42) protects the

myocardium against ischemia-reperfusion injury[J].

Nat Med, 2005, 11:298-304.

24 Zacharowski K, Zacharowski P, Reingruber S, et al.

Fibrin(ogen) and its fragments in the pathophysiology

and treatment of myocardial infarction[J]. J Mol Med,

2006, 84:469-477.

25 Kim S, Nadel JA. Fibrinogen binding to ICAM-1

promotes EGFR-dependent mucin production in

human airway epithelial cells[J]. Am J Physiol Lung

Cell Mol Physiol, 2009, 297:L174-L183.

26 Roux PP, Blenis J. ERK and p38 MAPK-activated

protein kinases:a family of protein kinases with

diverse biological functions[J]. Microbiol Mol Biol

Rev, 2004, 68:320-344.

27 Kevil CG, Payne DK, Mi re E, et al. Vascular

permeability factor/vascular endothelial cell growth

factor-mediated permeabilit y occur s th rough

disorganization of endothelial junctional proteins[J]. J

Biol Chem, 1998, 273:15099-15103.

28 Guo M, Wu MH, Granger HJ, et al. Transference

of recombinant VE-cadherin cytoplasmic domain

alters endothelial junctional integrity and porcine

microvascular permeability[J]. J Physiol, 2004,

554:78-88.